CLINICAL_TRIALS trial_result · 2025-08-20

Clinical Trial Update: A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet [Phase 2]

Phase 2 study of TAK-062 in adults with active celiac disease on a gluten-free diet has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Takeda | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-08-20